Association between LDL-C and risk of myocardial infarction in CKD

Journal of the American Society of Nephrology

Volumn 24, Issue 6, 2013, Pages 979-986

  Tonelli, Marcello ^a,b   Muntner, Paul ^c   Lloyd, Anita ^a   Manns, Braden ^d   Klarenbach, Scott ^a,b   Pannu, Neesh ^a   James, Matthew ^d   Hemmelgarn, Brenda ^d  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EZETIMIBE; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ABORIGINE; ADULT; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMORBIDITY; DEMENTIA; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HAZARD RATIO; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PARAPLEGIA; PRIORITY JOURNAL; PROTEINURIA; RISK ASSESSMENT; SOCIAL STATUS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

EID: 84878723826     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012080870     Document Type: Article

References (30)

1. Chronic Kidney Disease Prognosis ConsortiumMatsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT: Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis. Lancet 375: 2073-2081, 2010
2. Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR, Wiebe N, Tonelli M; Alberta Kidney Disease Network: Relation between kidney function, proteinuria, and adverse outcomes. JAMA 303: 423-429, 2010
3. Liu Y, Coresh J, Eustace JA, Longenecker JC, Jaar B, Fink NE, Tracy RP, Powe NR, KlagMJ: Association between cholesterol level andmortality in dialysis patients: Role of inflammation and malnutrition. JAMA 291: 451-459, 2004
4. Coresh J, Selvin E, Stevens LA,Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-2047, 2007
5. Kidney Disease Outcomes Quality Initiative (K/DOQI) Group: K/DOQI clinical practice guidelines formanagement of dyslipidemias in patients with kidney disease. Am J Kidney Dis 41[4 Suppl 3]: I-IV, S1-S91, 2003
6. Keys A, Menotti A, Aravanis C, Blackburn H, Djordevic BS, Buzina R, Dontas AS, Fidanza F, Karvonen MJ, Kimura N,Mohacek I, Nedeljkovic S, Puddu V, Punsar S, Taylor HL, Conti S, Kromhout D, Toshima H: The seven countries study: 2,289 deaths in 15 years. PrevMed 13: 141-154, 1984
7. Tobert JA: Lovastatin and beyond: The history of the HMG-CoA reductase inhibitors. Nat Rev Drug Discov 2: 517-526, 2003
8. Degoulet P, Legrain M, Réach I, Aimé F, Devriés C, Rojas P, Jacobs C: Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study. Nephron 31: 103-110, 1982
9. Iseki K, Yamazato M, Tozawa M, Takishita S: Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients. Kidney Int 61: 1887-1893, 2002
10. Kalantar-Zadeh K, Block G, Humphreys MH, McAllister CJ, Kopple JD: A low, rather than a high, total plasma homocysteine is an indicator of poor outcome in hemodialysis patients. J Am Soc Nephrol 15: 442-453, 2004
11. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD: Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 63: 793-808, 2003
12. Kalantar-Zadeh K: Recent advances in understanding the malnutritioninflammation- cachexia syndrome in chronic kidney disease patients: What is next? Semin Dial 18: 365-369, 2005
13. National Institutes of Health: Third Report of the National Cholesterol Education Program(NCEP) Expert Panel onDetection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), Bethesda, MD, National Institutes of Health, 2002
14. Tonelli M, Muntner P, Lloyd A, Manns BJ, Klarenbach S, Pannu N, James MT, Hemmelgarn BR; Alberta Kidney Disease Network: Risk of coronary events in people with chronic kidney disease compared with those with diabetes: A population-level cohort study. Lancet 380: 807-814, 2012
15. Palmer SC, Craig JC, Navaneethan SD, TonelliM, Pellegrini F, Strippoli GFM: Benefits and harms of statin therapy for persons with chronic kidney disease: A systematic review andmeta-analysis. Ann InternMed 157: 263-275, 2012
16. Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L,GazianoM, Kasiske B, Walker R,Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellström B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Grönhagen-Riska C, Dasgupta T, Lewis D, HerringtonW,MafhamM, MajoniW,Wallendszus K, GrimmR, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R; SHARP Investigators: The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): A randomised placebo-controlled trial. Lancet 377: 2181-2192, 2011
17. Garg AX, Blake PG, Clark WF, Clase CM, Haynes RB, Moist LM: Association between renal insufficiency and malnutrition in older adults: Results from the NHANES III. Kidney Int 60: 1867-1874, 2001
18. SarnakMJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, KlagMJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ,Wilson PW; American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention: Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation 108: 2154-2169, 2003
19. Strippoli GFM, Navaneethan SD, Johnson DW, Perkovic V, Pellegrini F, Nicolucci A, Craig JC: Effects of statins in patients with chronic kidney disease: Meta-analysis and meta-regression of randomised controlled trials. BMJ 336: 645-651, 2008
20. Tonelli M, Isles C, Curhan GC, Tonkin A, PfefferMA, Shepherd J, Sacks FM, Furberg C, Cobbe SM, Simes J, Craven T, West M: Effect of pravastatin on cardiovascular events in peoplewith chronic kidney disease. Circulation 110: 1557-1563, 2004
21. Grundy SM: Diabetes and coronary risk equivalency: What does it mean? Diabetes Care 29: 457-460, 2006
22. Muntner P, He J, Astor BC, Folsom AR, Coresh J: Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: Results from the atherosclerosis risk in communities study. J Am Soc Nephrol 16: 529-538, 2005
23. Kovesdy CP, Anderson JE, Kalantar-Zadeh K: Inverse association between lipid levels and mortality in men with chronic kidney disease who are not yet on dialysis: Effects of case mix and the malnutritioninflammation- cachexia syndrome. J Am Soc Nephrol 18: 304-311, 2007
24. Shlipak MG, Fried LF, Cushman M, Manolio TA, Peterson D, Stehman- Breen C, Bleyer A, Newman A, Siscovick D, Psaty B: Cardiovascular mortality risk in chronic kidney disease: Comparison of traditional and novel risk factors. JAMA 293: 1737-1745, 2005
25. Hemmelgarn BR, Clement F, Manns BJ, Klarenbach S, James MT, Ravani P, Pannu N, Ahmed SB, MacRae J, Scott-Douglas N, Jindal K, Quinn R, Culleton BF, Wiebe N, Krause R, Thorlacius L, Tonelli M: Overview of the alberta kidney disease network. BMC Nephrol 10: 30, 2009
26. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009
27. Sin DD, Svenson LW, Cowie RL,Man SF: Can universal access to health care eliminate health inequities between children of poor and nonpoor families? A case study of childhood asthma in Alberta. Chest 124: 51-56, 2003
28. Austin PC, Daly PA, Tu JV: Amulticenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario. Am Heart J 144: 290-296, 2002
29. Harrell FE Jr: Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis, New York, Springer, 2001
30. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, Saunders LD, Beck CA, Feasby TE, Ghali WA: Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43: 1130-1139, 2005